Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Hong Yuan, MS

MicuRx Pharmaceuticals Inc, Foster City, CA, USA, China

Disclosure(s): No financial relationships to disclose

Poster(s):

1699 - Efficacy and Safety by BMI Category and Gender in Contezolid and Contezolid Acefosamil Phase 2 and Phase 3 Skin Infection Clinical Trials
Saturday, October 22, 2022
12:15 PM – 1:30 PM US ET
1700 - Efficacy and Safety in Subjects with Renal Impairment in Contezolid and Contezolid Acefosamil Phase 2 and Phase 3 Skin Infection Clinical Trials
Saturday, October 22, 2022
12:15 PM – 1:30 PM US ET
1701 - Pharmacokinetics in Subjects with Renal Impairment in a Contezolid Complicated Skin and Soft Tissue Infection Phase 3 Clinical Trial
Saturday, October 22, 2022
12:15 PM – 1:30 PM US ET
1702 - Platelet Counts in Contezolid Complicated Skin and Soft Tissue Infection Phase 2 and Phase 3 Clinical Trials
Saturday, October 22, 2022
12:15 PM – 1:30 PM US ET